The Daily Upside

Advisor Upside

Financial advisor news, market insights, and practice management essentials.

Does the 100% Equity Portfolio Make Sense? Hmm, Maybe

Photo by m. via Unsplash

2 min read
Prediction Markets Are Worrying Wealth Managers

Photo by Naser Tamimi via Unsplash

2 min read
How New FPA CEO Dennis Moore Plans to Shake Up Planning

Photo via Financial Planning Association

5 min read

Consumer

Butterball Battle Begins for Retailers Rolling Out Holiday Deals

Photo via Richard B. Levine/Newscom

Target on Wednesday said its meal kit for four will cost less than $20 this year before tax, or about $5 a person.

2 min read

Economics

Can the Fed Get Missing Economic Data in Time for Rate-Cut Decision?

Photo via BONNIE CASH/UPI/Newscom

While a stop-gap funding deal is in place, the government still has some work to do to fill in its backlog of missing economic data.

2 min read

Advisor Upside

Behind Schwab’s $660M Deal for Private Asset Marketplace Forge

Photo by Mike Mozart via CC BY 2.0

Investors have bought and sold more than $17 billion in private company shares using the platform.

2 min read

ETF Upside

All Things ETFs: Simplified and Actionable

International Economics

China Reopening to US Soybean Imports

Photo via Jerry Mennenga/ZUMAPRESS/Newscom

China stopped buying US soybeans altogether in May, two months after suspending the import licenses of US-based CHS Inc.

2 min read

Photo illustration by Connor Lin / The Daily Upside, Photos by Sabelskaya and Gyzele via iStock

Economics

US Tariffs Chew a Hole in Retailers’ (and Shoppers’) Christmas Stockings

The US has basically imposed tariffs on Christmas this year: Trees, ornaments and even gifts. Now, both shoppers and sellers feel Grinchy.

6 min read
Photo illustration by Connor Lin / The Daily Upside, Photos by Tomwang112 and VvoeVale via iStock

Advisor Upside

Gen X Clients Need Help Saving for Retirement. What’s The Cure?

How to help the ‘Whatever’ generation boost savings and live comfortably in their golden years.

4 min read
Photo via Cfoto/ZUMAPRESS/Newscom

Healthcare

CEO Says AstraZeneca Can ‘Absorb’ Costs of Trump-Driven US Deals

AstraZeneca is the biggest drugmaker in Britain and its £193 billion ($253 billion) market capitalization tops the London Stock Exchange.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.